Intermediate dose interferon alpha 2b (IFN alpha 2b) in adiuvant treatment for Malignant Melanoma

被引：0
|
作者：
Savio, G. [1 ]
Calabria, C. [1 ]
Leonardi, V. [1 ]
Laudani, A. [1 ]
Pepe, A. [1 ]
Blasi, L. [1 ]
Usset, A. [1 ]
Rondello, G. [1 ]
Agostara, B. [1 ]
机构：
[1] Hosp M Ascoli, Dept Oncol, Div Med Oncol, ARNAS CIVICO, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [21] Pegylated interferon alpha 2b induces less thyroid dysfunction than standard interferon alpha 2b in the treatment of chronic hepatitis C
    Patel, Y
    Chapalamadugu, R
    Ramdhaney, S
    Baradarian, R
    Iswara, K
    Tenner, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S87 - S88
  • [22] Hepatitis C virus (HCV) genotype change after treatment with interferon alpha 2B (INF-alpha 2b).
    PerezJimenez, O
    Kapur, J
    Szentendrei, T
    Bednarek, J
    Sjogren, MH
    [J]. HEPATOLOGY, 1996, 24 (04) : 1738 - 1738
  • [23] Comparisons of Pharmacokinetic Profiles of High Dose Interferon-α2b (IFN) and peginterferon-α2b (PEG-IFN) in Melanoma Patients
    Xu, C.
    Daud, A. I.
    DeConti, R. C.
    Floren, L. C.
    Hwu, W. J.
    Guminsk, A.
    Sabesan, S.
    Batageli, E.
    Prasad, P.
    Yver, A.
    Sondak, V. K.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1122 - 1122
  • [24] IMMUNOMODULATORY MECHANISMS INDUCED BY IFN ALPHA 2B
    Taylor, Simon
    Yang, David
    Galatowicz, Grazyna
    Nouraeinejad, Ali
    Calder, Virginia
    Lightman, Sue
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S128 - S128
  • [25] Thermal stability of the WHO international standard of interferon alpha 2b (IFN-α2b):: Application of new reporter gene assay for IFN-α2b potency determinations
    Caserman, Simon
    Menart, Viktor
    Das, Rose Gaines
    Williams, Stella
    Meager, Anthony
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 319 (1-2) : 6 - 12
  • [26] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [27] Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study
    Cameron, DA
    Cornbleet, MC
    Mackie, RM
    Hunter, JAA
    Gore, M
    Hancock, B
    Smyth, JF
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (09) : 1146 - 1149
  • [28] Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study
    D A Cameron
    M C Cornbleet
    R M Mackie
    J A A Hunter
    M Gore
    B Hancock
    J F Smyth
    [J]. British Journal of Cancer, 2001, 84 : 1146 - 1149
  • [29] Interferon-alpha 2b interaction with acenocoumarol
    Serratrice, J
    Durand, JM
    Morange, S
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (01) : 89 - 89
  • [30] Interferon Alpha 2a and 2b in Ophthalmology: A Review
    Lewczuk, Natalia
    Zdebik, Alexander
    Boguslawska, Joanna
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (05): : 259 - 272
12345